跳至主要内容
临床试验/NCT05762965
NCT05762965已完成不适用

Effect of Galacto-oligosaccharides (GOS) on Faecal Gut Microbiota in Adult Women

Wageningen University and Research1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2023年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
1
主要终点
faecal abundance of Bifidobacterium

研究概览

简要总结

Within the Denali study the effect of 3 weeks intervention with GOS on the abundance of Bifidobacterium in faecal samples will be investigated.

详细描述

This randomized, parallel, double-blinded intervention study of 6 weeks will include 88 females, who will consume GOS for three consecutive weeks. Faecal samples will be collected at several time points to measure microbiota composition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Apparently healthy women
  • Aged between 40 - 70 year
  • Body Mass Index (BMI) between 18.5 - 30 kg/m2

排除标准

  • Having a gastro-intestinal disease, such as celiac disease, Crohn's disease, Ulcerative colitis, or diagnosed irritable bowel syndrome;
  • Having a history of intestinal surgery that might interfere with study outcomes. This does not include an appendectomy or cholecystectomy;
  • Diagnosed with diabetes mellitus;
  • Use of medication that may influence the study results, such as laxatives, lactase preparations, metformin, antibiotics, proton pomp inhibitors, antipsychotics, NSAID's (judged by our research physician);
  • Self-perceived and diagnosed constipation;
  • Having a food allergy to cow's milk or being lactose intolerant;
  • Self-reported slimming, medically prescribed or other diets
  • Reported weight loss or weight gain of >5kg in the month prior to screening
  • Use of (foods with) pre-, pro-, syn- and/or postbiotics* (should be stopped at least 4 weeks before the start of the study), or other supplements that can influence the study results (to be determined by the medical investigator);
  • History of side effects with the use of prebiotic supplements
  • Use of antibiotic treatment less than 3 months before start of the study
  • Pregnant or lactating (or having the wish to become pregnant during the study period, self-reported);
  • Not able to comply with study procedures;
  • Use of drugs (should be stopped at least 4 weeks before the study);
  • Alcohol intake ≥7 glasses of alcoholic beverages per week, on average
  • Participation in another clinical trial at the same time;
  • Being an employee of the Food, Health & Consumer Research group of Wageningen Food & Biobased Research or employee of FrieslandCampina R&D.

结局指标

主要结局

faecal abundance of Bifidobacterium

时间窗: At week 3 (end intervention)

faecal abundance of Bifidobacterium.

次要结局

  • Faecal microbiota composition(At week 3 (end intervention))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diederik Esser

Project leader clinical trials

Wageningen University and Research

研究点 (1)

Loading locations...

相似试验